This week: Millions of courses of a COVID-19 oral antiviral sent to the US government for distribution throughout the country; a draft guidance for novel nonopioid analgesic development; strangulation warning for enteral feeding tubes; a new treatment approved for cold agglutinin disease; and a novel therapy under review for HFrEF.